NOTE: Analysis and opinions expressed by Jack are his and his alone, and are not to be interpreted as a reflection of opinions by his current or former employers.
In this episode of Hims House, Jonathan Stern, Louis Stevens, and Dr. H are joined by a special guest, Jack, a former sell-side analyst. Jack provides a comprehensive analysis of the Hims & Hers business, rooted in his years of following the company since 2022. The discussion kicks off with an overview of the financial industry, contrasting the roles of sell-side and buy-side analysts. Jack elaborates on his interest in following HIMS, emphasizing the company's successful transition from a patient-centric to a consumer-centric healthcare provider. The episode highlights a recent Bank of America report predicting a revenue shortfall for HIMS, exploring credit card data intricacies and deferred revenue impacts. Finally, the conversation delves into HIMS' long-term prospects, potential regulatory hurdles, international viability, and their unique market position.
00:00 Introduction
00:42 Understanding the Sell Side vs. Buy Side
02:17 Jack's Interest in HIMS
03:46 Bank of America Report Analysis
05:42 Deferred Revenue and Credit Card Data
11:40 Impact of Amazon on HIMS
18:32 Consumer vs. Patient Behavior
22:07 Cash Pay Option in Healthcare
26:22 HIMS' Long-Term Vision and International Expansion
31:35 Debating the Future of Diabetes Care
32:41 Challenges in High Acuity Care
34:04 Teladoc and Livongo: A Case Study
36:07 Impact of COVID on Digital Health
40:21 Consumer vs. Patient Psychology
47:01 The Future of Weight Loss and Diabetes Treatment
52:08 2025 Predictions and Key Indicators
Get full access to Hims House at
himshouse.substack.com/subscribe
